Merck KGaA Profit Beats Estimates on Cost-Cutting

May 14 (Bloomberg) -- Merck KGaA, the German maker of cancer drug Erbitux, said first-quarter profit rose on higher-than-expected savings from a reorganization program, and forecast it will achieve 2014 targets a year ahead of schedule. Mark Barton reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Ukraine's Poroshenko: Confident Good U.S. Ties Continue
03:58 - President of Ukraine Petro Poroshenko expresses his confidence in continued good ties between Ukraine and the United States and discusses the world's need for NATO and the future of trade sanctions against Russia. He speaks from the World Economic Forum in Davos, Switzerland on "Bloomberg Surveillance." (Source: Bloomberg)
  • China's Xi Defends Globalization at World Economic Forum
  • NYT's CEO Thompson on Donald Trump and Fake News
  • NYT's CEO Thompson Expects a 'Great Year for News'